Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Proceedings of the National Academy of Sciences of the United States of America
Jun W KimJennifer R Cochran

Abstract

Interleukin-6 (IL-6) family cytokines signal through multimeric receptor complexes, providing unique opportunities to create novel ligand-based therapeutics. The cardiotrophin-like cytokine factor 1 (CLCF1) ligand has been shown to play a role in cancer, osteoporosis, and atherosclerosis. Once bound to ciliary neurotrophic factor receptor (CNTFR), CLCF1 mediates interactions to coreceptors glycoprotein 130 (gp130) and leukemia inhibitory factor receptor (LIFR). By increasing CNTFR-mediated binding to these coreceptors we generated a receptor superagonist which surpassed the potency of natural CNTFR ligands in neuronal signaling. Through additional mutations, we generated a receptor antagonist with increased binding to CNTFR but lack of binding to the coreceptors that inhibited tumor progression in murine xenograft models of nonsmall cell lung cancer. These studies further validate the CLCF1-CNTFR signaling axis as a therapeutic target and highlight an approach of engineering cytokine activity through a small number of mutations.

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T TagaT Kishimoto
Feb 1, 1994·Annals of Neurology·F DittrichM Sendtner
Jun 1, 1997·Nature Biotechnology·E T Boder, K D Wittrup
Mar 17, 2000·Journal of Neuro-oncology·J WeisH Halfter
Jul 24, 2001·Medical and Pediatric Oncology·H KurodaT Sawada
Apr 10, 2003·JAMA : the Journal of the American Medical Association·Mark P EttingerHans-Peter Guler
Nov 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ruth GoldbergNathan Karin
Aug 12, 2005·Nature Methods·Anne M TaylorNoo Li Jeon
Mar 1, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xin HuJianren Gu
Jan 13, 2009·Eye·A W Taylor
Sep 8, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Blake T GurfeinGareth R John
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kang ZhangGeorge A Williams
Dec 6, 2012·Translational Neurodegeneration·April M Weissmiller, Chengbiao Wu
Dec 19, 2012·Immunity·Christopher A Hunter, Rob Kastelein
Nov 26, 2013·The Journal of Clinical Investigation·Shu-Chen LiuYu-Sun Chang
Feb 12, 2014·Methods in Molecular Biology·James A Van Deventer, Karl Dane Wittrup
Feb 21, 2014·Seminars in Immunology·Koji Taniguchi, Michael Karin
Apr 22, 2015·Nature Immunology·Christopher A Hunter, Simon A Jones
Jun 11, 2015·Methods in Molecular Biology·Alessandro AngeliniK Dane Wittrup
Jul 19, 2015·Cytokine & Growth Factor Reviews·Nicos A Nicola, Jeffrey J Babon
Aug 9, 2015·Autoimmunity Reviews·Rakeshchandra R MekaKamal D Moudgil
Apr 4, 2017·Current Opinion in Chemical Biology·Jun Woo Kim, Jennifer R Cochran
Jun 18, 2017·Cold Spring Harbor Perspectives in Biology·Stefan Rose-John
Sep 14, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarah PasquinJean-François Gauchat
Sep 27, 2018·Nature Reviews. Immunology·Simon A Jones, Brendan J Jenkins
Oct 8, 2018·Ophthalmology·Emily Y ChewUNKNOWN Macular Telangiectasia Type 2-Phase 2 CNTF Research Group
Apr 18, 2019·Immunity·Sujin KangTadamitsu Kishimoto

❮ Previous
Next ❯

Citations

Feb 19, 2021·The Journal of Biological Chemistry·Conan K Wang, David J Craik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.